Investors Research Corp’s Aspire Biopharma ASBP Stock Holding History

Investors Research Corp’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	-$210	–	1122
2023 Q1	–	Hold	0	–	–	–	1092
2022 Q4	–	Hold	0	–	–	–	1107
2022 Q3	–	Hold	0	–	–	–	1145
2022 Q2	–	Hold	0	–	–	–	1162

Other funds holding ASBP

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return